Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Unglik

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Inflammatory Bowel Diseases|December 11, 2008
Bilateral parotidomegaly following anaphylaxis to infliximabArun Gupta, Gary Unglik, Finlay A Macrae
The New England Journal of Medicine|October 25, 2013
Deficiency in complement factor BCharlotte Slade, Julian Bosco, Gary Unglik, et al.
Plos One|June 20, 2020
Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage studyEmma Foster, Michael J Malloy, Vilija G Jokubaitis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 23, 2023
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)Jeremy S McComish, Charlotte A Slade, Luke Buizen, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2021
Therapeutic options for CTLA-4 insufficiencyDavid Egg, Ina Caroline Rump, Noriko Mitsuiki, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2018
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjectsCharlotte Schwab, Annemarie Gabrysch, Peter Olbrich, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Inflammatory Bowel Diseases|December 11, 2008
Bilateral parotidomegaly following anaphylaxis to infliximabArun Gupta, Gary Unglik, Finlay A Macrae
The New England Journal of Medicine|October 25, 2013
Deficiency in complement factor BCharlotte Slade, Julian Bosco, Gary Unglik, et al.
Plos One|June 20, 2020
Increased risk of cervical dysplasia in females with autoimmune conditions-Results from an Australia database linkage studyEmma Foster, Michael J Malloy, Vilija G Jokubaitis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 23, 2023
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM)Jeremy S McComish, Charlotte A Slade, Luke Buizen, et al.
The Journal of Allergy and Clinical Immunology|June 10, 2021
Therapeutic options for CTLA-4 insufficiencyDavid Egg, Ina Caroline Rump, Noriko Mitsuiki, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2018
Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjectsCharlotte Schwab, Annemarie Gabrysch, Peter Olbrich, et al.
Pageof 1